EU Battery Regulation: What medical device manufacturers need to know
The EU plans to replace the existing Directive 2006/66/EC with the new EU Regulation on batteries and waste batteries (“Battery Regulation”). This article clarifies,
DetailsOpen-source software as a medical device?
University institutions in particular regularly publish medical software as open source. This raises doubts as to whether this open-source software counts as a medical device and what regulatory and (product) liability risks are involved. This article provides a quick overview.
DetailsCombination products: Applicable law and regulatory requirements (EU law)
Combination products consist of the combination of a medical device and a medicinal product. Since both medical device and medicinal product law could be applicable here, there are some special features that must be taken into account for products of this type. In this article, you learn more about
DetailsValidating ChatGPT: What medical device manufacturers need to consider
Is there a duty for medical device manufacturers for validating ChatGPT and other LLMs that they use in the development, production, approval, and monitoring of their products? If so, how can this be achieved with models that deliver non-deterministic results? This technical article provides answers to these questions and to the question of what your…
DetailsASCA: Accreditation Scheme for Conformity Assessment
ASCA stands for Accreditation Scheme for Conformity Assessment. The procedure is intended to accelerate conformity assessments and, thus, approval procedures. However, it is not applicable to all devices or all markets. This article explains who benefits from ASCA and how the procedure works.
DetailsWhat the AI Act means for medical device and IVD manufacturers
The EU AI Act has been published. Many manufacturers of medical devices and IVD, as well as other healthcare players, are faced with the major task of understanding the 140+ pages of legal text and complying with the requirements. Note: Infringements/violations of the AI Act are punishable by a fine of up to 7% of…
DetailsSafety classes according to IEC 62304
IEC 62304 defines safety classes so that medical device manufacturers can tailor the effort required for software documentation to the degree of harm that could be caused by a software error. This expert article helps to determine the safety classes and, if necessary, reduce them in order to minimize the effort required while still ensuring…
DetailsThe FDA eSTAR Program: should or must you take part?
With the eSTAR Program, the FDA aims to increase the efficiency of approval procedures (e.g., the 510(k) procedure) through digitalization. The Johner Institute is working with the FDA on the further development of eStar. This article tells you how forward-looking this approach is and whether you should or even must take part.
DetailsClassification of in-vitro diagnostic medical devices: how to avoid a too-high classification
The classification of in-vitro diagnostics (IVD) can have far-reaching consequences, as it has an impact on the conformity assessment procedure, certification audits, and, thus, on market launch. To help you prevent the unnecessary allocation of your IVD product to a high-risk class, this article provides an overview of
DetailsIntended purpose and intended use: More consequences than you think!
The correct and precise formulation of the intended purpose of medical devices and in vitro diagnostic medical devices (IVD) is crucial for their successful development and approval. However, even the definitions of terms and the connection between intended purpose and intended use make it difficult to achieve clarity and precision. This article reveals how to…
Details